Home > Insider Trading > Filing (0001127602-22-028072)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492422	Apellis Pharmaceuticals Inc.	APLS	Pharmaceutical Preparations (2834)	271537290

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1658080	Cedric Francois	C/O Apellis Pharmaceuticals, Inc. Waltham MA 02451	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2022-04-25	12,500	$0.00	943,440	No	4	J	Direct
Common Stock	Acquisiton	2022-12-19	28,200	$2.67	971,640	No	4	M	Direct
Common Stock	Acquisiton	2022-12-19	15,000	$3.76	986,640	No	4	M	Direct
Common Stock	Acquisiton	2022-12-19	6,688	$14.95	993,328	No	4	M	Direct
Common Stock	Disposition	2022-12-19	3,751	$51.97	989,577	No	4	S	Direct
Common Stock	Disposition	2022-12-19	24,449	$52.07	965,128	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	J	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-19	28,200	$0.00	28,200	$2.67
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-19	15,000	$0.00	15,000	$3.76
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-19	6,688	$0.00	6,688	$14.95

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
450,000	2023-12-04	No	4	M	Direct
258,840	2026-02-06	No	4	M	Direct
273,312	2028-02-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	300,000	Indirect	The Francois Grossi Trust
Common Stock	234,411	Indirect	The Francois-DuBois Educational Trust

Footnotes

This represents the cancellation of a PSU awards granted on 01/28/2021 that was originally reported in table I upon grant. The performance metrics were not met.
This is a scheduled exercise & sale from 10b5-1 plan adopted September 13, 2022 .
Sale price within range of $1. Min. $50.695 - Max. $51.680
Sale price within range of $1. Min. $51.695 - Max. $52.400
The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
This option was granted on December 5, 2013 and fully vested.
This option was granted on February 8, 2016 and fully vested.
This option was granted on February 16, 2018 and will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.